These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22647868)

  • 1. Sun exposure and the use of sunscreen among rheumatology inflammatory arthropathy patients receiving anti-tumor necrosis factor therapy.
    McKeogh J; O'Connor MB; Bond U; Swan J; Phelan MJ
    J Clin Rheumatol; 2012 Jun; 18(4):205-6. PubMed ID: 22647868
    [No Abstract]   [Full Text] [Related]  

  • 2. Is sunscreen use for melanoma prevention valid for all sun exposure circumstances?
    Autier P; Boniol M; Doré JF
    J Clin Oncol; 2011 May; 29(14):e425-6; author reply e427. PubMed ID: 21464415
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendation: daily sun protection in the prevention of chronic UV-induced skin damage.
    Elsner P; Hölzle E; Diepgen T; Grether-Beck S; Hönigsmann H; Krutmann J; Scharffetter-Kochanek K; Schwarz T; Luger T
    J Dtsch Dermatol Ges; 2007 Feb; 5(2):166-73. PubMed ID: 17274786
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-tumor necrosis factor agents are mostly used in patients with established rheumatoid arthritis compared to early disease -- a reflection of adequate clinical practice.
    Haraoui B
    J Rheumatol; 2009 Aug; 36(8):1561-2. PubMed ID: 19671804
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.
    Rosner I; Haddad A; Boulman N; Feld J; Avshovich N; Slobodin G; Rozenbaum M
    Rheumatology (Oxford); 2007 Sep; 46(9):1508; author reply 1508-9. PubMed ID: 17684027
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis.
    Gonzalez-Gay MA; Garcia-Unzueta MT; Berja A; Vazquez-Rodriguez TR; Gonzalez-Juanatey C; de Matias JM; Martin J; Dessein PH; Llorca J
    Ann Rheum Dis; 2008 Nov; 67(11):1644-6. PubMed ID: 18854515
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recommendations of the German Society of Rheumatology for therapy with tumor necrosis factor inhibitors. Pharmacotherapy Committee of the German Society of Rheumatology].
    Z Rheumatol; 2000 Aug; 59(4):291-2. PubMed ID: 11013988
    [No Abstract]   [Full Text] [Related]  

  • 9. [Proposal for anti-TNFalpha therapy in adult patients with rheumatoid arthritis].
    Curković B; Babić-Naglić D; Morović-Vergles J; Anić B; Grazio S
    Reumatizam; 2007; 54(1):16-9. PubMed ID: 18450272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of sunscreen reapplication regimens in children exposed to ambient sunlight.
    Odio MR; Veres DA; Goodman JJ; Irwin C; Robinson LR; Martínez J; Kraus AL
    Photodermatol Photoimmunol Photomed; 1994 Jun; 10(3):118-25. PubMed ID: 7947191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-tumour necrosis factor {alpha} therapy in patients with rheumatoid arthritis results in a significant and long-lasting decrease of concomitant glucocorticoid treatment.
    Naumann L; Huscher D; Detert J; Spengler M; Burmester GR; Buttgereit F
    Ann Rheum Dis; 2009 Dec; 68(12):1934-6. PubMed ID: 19910303
    [No Abstract]   [Full Text] [Related]  

  • 13. Swollen joint count as a predictor of response to anti-tumor necrosis factor alpha therapy in rheumatoid arthritis: comment on the article by Sokka and Pincus.
    Estrach C; Mpofu S; Thompson RN; Williams E; Abernethy VE; Moots RJ
    Arthritis Rheum; 2003 Dec; 48(12):3611-3; author reply 3613-5. PubMed ID: 14674016
    [No Abstract]   [Full Text] [Related]  

  • 14. Stay out of the sun.
    Palmer R
    Nurs Stand; 2002 Aug 7-13; 16(47):27. PubMed ID: 12219447
    [No Abstract]   [Full Text] [Related]  

  • 15. Summer sun exposure: knowledge, attitudes, and behaviors of Midwest adolescents.
    Robinson JK; Rademaker AW; Sylvester JA; Cook B
    Prev Med; 1997; 26(3):364-72. PubMed ID: 9144761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tumor necrosis factor inhibitors in patients with RA.
    Trethewey P
    JAAPA; 2002 Sep; 15(9):23-4, 27, 30 passim. PubMed ID: 12395668
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-tumour necrosis factor alpha therapy in patients with impaired renal function.
    Hueber AJ; Tunc A; Schett G; Manger B
    Ann Rheum Dis; 2007 Jul; 66(7):981-2. PubMed ID: 17337474
    [No Abstract]   [Full Text] [Related]  

  • 18. Sunscreens for non-dermatologists: what you should know when counseling patients.
    Stechschulte SA; Kirsner RS; Federman DG
    Postgrad Med; 2011 Jul; 123(4):160-7. PubMed ID: 21681000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of recreational sun exposure of residents of San Diego, California.
    Newman WG; Agro AD; Woodruff SI; Mayer JA
    Am J Prev Med; 1996; 12(3):186-94. PubMed ID: 8743874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
    Kekow J; Welte T; Kellner U; Pap T
    Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.